An open study of tioconazole 1% dermal cream in patients with pityriasis versicolor.

Sixty five cases of pityriasis versicolor were treated with 1% Tioconazole dermal cream twice daily for three weeks in an open study to determine its efficacy. They were assessed before treatment and at one, two, three and six weeks after initiation of therapy. Fifty three patients (81.5%) were completely cured while twelve patients (18.5%) had recurrence on discontinuation of therapy. Five patients (7.5%) had side effects in the form of itching and burning which however, did not necessitate interruption of treatment (JPMA 34: 361 1984).